iPhone | iPad
Android
Huawei
Omicron variant is highly contagious and can even infect vaccinated/infected people, say experts
KT APPDOWNLOAD
Covid-19: Small study shows antibody growth from AstraZeneca, Sputnik Light vaccine mix
Photo: Reuters
Moscow - The data was collected from 20 people who took part in a 100-person study in Azerbaijan that began in February
A small-scale clinical study of the combined use of the AstraZeneca and Sputnik Light vaccines against Covid-19 has shown strong antibody growth in a majority of the study’s participants, the Russian Direct Investment Fund said on Monday.
The data was collected from 20 people who took part in a 100-person study in Azerbaijan that began in February. They first received the AstraZeneca shot followed by the one-dose Russian-made Sputnik Light shot 29 days later, RDIF said.
ALSO READ:
>> Covid-19: Combining AstraZeneca and mRNA vaccines is effective
>> Russia launches Sputnik Light vaccine into wide circulation
“According to the results of the interim analysis, a fourfold or higher increase in neutralising antibodies to the spike protein (S-protein) of the SARS-CoV-2 was found in 85 per cent of the volunteers on the 57th day of the study,” RDIF said.
More news from coronavirus
Doctors explain how some people can come into contact with a positive case without getting the virus themselves
Globally, cases decreased by nine per cent between July 25 and 31, as compared to the previous week
Over 178.2 million PCR tests have been conducted in the country so far
Total active cases stand at 18,841
Total active cases stand at 18,647
US President remains 'fever free and in good spirits'
Over 177.7 million PCR tests have been conducted in the country so far